ÂÜÀòÂÒÂ×

Dr Jeremy Paull has more than 20 years’ experience in pharmaceutical and medtech product development, regulatory affairs, and commercialisation. Jeremy has managed all aspects of multiple development and commercialisation projects for products in areas including HIV/STIs, COVID-19, women’s health, dermatology, and oncology, and has achieved market approval and commercialisation of medical device and combination products in global markets. Jeremy has also advanced pharmaceutical products through late stage, global phase 3 clinical trials, and led engagement with global regulatory agencies (FDA, EMA, TGA, MHRA, PMDA).

Jeremy leads a team of senior technical managers and was Principal Investigator for two concurrent US NIH-funded, multi-year, multi-million dollar research and product commercialisation programs involving collaborations with world-renowned, local and international academic institutions and commercial partners. He is a current member of AusBiotech’s AusMedtech Regulatory Affairs Expert Panel and past member of the AusMedtech Victoria Committee.

Jeremy has been a member of the executive leadership team of Starpharma since 2003 and has completed executive leadership training at Kellogg School of Management at Northwestern University, Melbourne Business School, and Australian Graduate School of Management at UNSW. He joined Starpharma in 2001 from medtech company, Norwood Abbey, and has a PhD in pharmacology from Monash University.